Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein Levels in Inflammatory Bowel Disease Patients across Racial Groups
Serum LRG demonstrates consistent diagnostic value in both Japanese and non-Japanese patients with IBD, supporting its broader clinical applicability across diverse populations.
Authors
- Yohei Mikami (ORCID: https://orcid.org/0000-0001-5104-4415)
- Hiroki Kiyohara (ORCID: https://orcid.org/0000-0001-6315-3782)
- Masataka Taguri (ORCID: https://orcid.org/0000-0001-8902-0056)
- Takanori Kanai∥ (ORCID: https://orcid.org/0000-0002-1466-4532)
- Nobuhiro Nakamoto (ORCID: https://orcid.org/0000-0001-5203-7444)
- Yasuhiro Aoki (ORCID: https://orcid.org/0000-0002-5733-500X)
- Shinya Sugimoto (ORCID: https://orcid.org/0000-0002-1560-1605)
- Yusuke Yoshimatsu
Institutions
- Tokyo Medical University (JP)
- Keio University (JP)
- Tokyo Medical Center (JP)
- National Hospital Organization (JP)
Publication Details
- Journal
- Inflammatory Intestinal Diseases
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1159/000549382
- Primary Topic
- Clusterin in disease pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Foundation for Applied Enzymology
- Japan Agency for Medical Research and Development
- Keio University
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology